Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05232279Phase 3Completed
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) (3 arms), sponsored by RDC Clinical. Primary endpoints: International Index of Erectile Function at 12 weeks and Erection Hardness Score at 12 weeks. Started Apr 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05232279.